3i announces sale of OneMed generating proceeds of c. £100 million

3i Group plc (“3i”), and funds managed by 3i, have entered into a sale and purchase agreement to sell their investment in OneMed, the leading medical supplies distributor in Northern Europe, to Nalka Invest AB.

Proceeds to 3i will be c. £100m. The transaction is expected to complete in March 2019, subject to customary antitrust approvals.

3i invested in OneMed in 2011. During 3i’s ownership, the company successfully strengthened its market positions in Sweden, Denmark and Finland and built its international footprint through three strategic acquisitions in the Netherlands and a major expansion in Norway.   

- Ends-

Download this press release   

For further information, contact:

Notes to editors:

 About 3i Group

3i is a leading international investment manager focused on mid-market private equity and infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com

About OneMed

OneMed is the leading medical supplies distributor in Northern Europe serving customers in the healthcare industry with reliable and efficient solutions for their entire need of supplies and related services. By adding a service offering (advanced decision support, healthcare procedure education, product range planning and streamlined ordering procedures) OneMed presents a comprehensive medical supplies solution where OneMed in collaboration with customers improves healthcare outcome, thus lowering total healthcare costs, improving the quality of care and creating a unique position in a non-cyclical subsector driven by structural growth themes.

Regulatory information

This transaction involved a recommendation of 3i Investments plc, advised by 3i Benelux.